89 results
Page 2 of 5
10-K
EX-10.51
cft7hpox1siqlm pjl
12 Feb 18
Annual report
12:00am
10-K
EX-10.20
50lgx
12 Feb 18
Annual report
12:00am
10-K
EX-10.44
80mempxo2gdn5ldm
12 Feb 18
Annual report
12:00am
10-K
EX-10.32
8rep10
12 Feb 18
Annual report
12:00am
6-K
EX-99.1
o5c3 228wprru
18 Aug 17
Teva Announces Exclusive Launch of Generic Axiron® In the United States
12:00am
6-K
oo534
30 Oct 14
Current report (foreign)
12:00am
6-K
EX-99.1
66fixs0
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
8llylgcdvngdh887mu8k
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
dh58vfs350 plcj
31 Oct 13
Current report (foreign)
12:00am
6-K
EX-99.1
ajsys795o5
23 Sep 13
Teva Announces Favorable Court Ruling In Azilect® Patent Infringement Litigation Against Mylan
12:00am
6-K
cjqrga ptlnwkyfg7q
2 May 13
Current report (foreign)
12:00am
6-K
EX-99.1
r5upe5n 5kxd
20 Mar 13
Live Filing
12:00am
6-K
EX-99.1
nl1xt79x9l4
14 Mar 13
Teva to Present New Research on CNS Product Portfolio and Pipeline at 2013 American Academy of Neurology Annual Meeting
12:00am
6-K
EX-99.1
aumson4cxy ufek84c0z
5 Feb 13
Teva Announces First Patient Enrolled In Largest Clinical Study to Date Evaluating Azilect® for Mild Cognitive Impairment In Parkinson’s Disease
12:00am
6-K
kyut4y
1 Nov 12
Current report (foreign)
12:00am